TY - JOUR
T1 - Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in India
AU - Mishra, Anshuman
AU - Sundaravadivel, Pandarisamy
AU - Tripathi, Sunil Kumar
AU - Jha, Rajan Kumar
AU - Badrukhiya, Jaydeep
AU - Basak, Nipa
AU - Anerao, Isha
AU - Sharma, Akshay
AU - Idowu, Ajayi Ebenezer
AU - Mishra, Abhishek
AU - Pandey, Sonika
AU - Kumar, Umesh
AU - Singh, Sakshi
AU - Nizamuddin, Sheikh
AU - Tupperwar, Nitin C.
AU - Jha, Aditya Nath
AU - Thangaraj, Kumarasamy
N1 - Publisher Copyright:
© 2018 The Authors
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Background: The host genetic factors play important role in determining the outcome of visceral leishmaniasis (VL). Macrophage migration inhibitory factor (MIF) is an important host cytokine, which is a key regulator of innate immune system. Genetic variants in MIF gene have been found to be associated with several inflammatory and infectious diseases. Role of MIF is well documented in leishmaniasis diseases, including Indian visceral leishmaniasis, where elevated level of serum MIF has been associated with VL phenotypes. However, there was no genetic study to correlate MIF variants in VL, therefore, we aimed to study the possible association of three reported MIF gene variants −794 CATT, −173G > C and non-coding RNA gene LOC284889 in Indian VL phenotype. Methods: Study subjects comprised of 214 VL patients along with ethnically and demographically matched 220 controls from VL endemic regions of Bihar state in India. Results: We found no significant difference between cases and controls in allelic, genotypic and haplotype frequency of the markers analysed [-794 CATT repeats (χ2 = 0.86; p = 0.35; OR = 0.85; 95% CI = 0.61–1.19); −173 G > C polymorphism (χ2 = 1.11; p = 0.29; OR = 0.83; 95% CI = 0.59–1.16); and LOC284889 (χ2 = 0.78; p = 0.37; OR = 0.86; 95% CI = 0.61–1.20)]. Conclusion: Since we did not find any significant differences between case and control groups, we conclude that sequencing of complete MIF gene and extensive study on innate and adaptive immunity genes may help in identifying genetic variations that are associated with VL susceptibility/resistance among Indians.
AB - Background: The host genetic factors play important role in determining the outcome of visceral leishmaniasis (VL). Macrophage migration inhibitory factor (MIF) is an important host cytokine, which is a key regulator of innate immune system. Genetic variants in MIF gene have been found to be associated with several inflammatory and infectious diseases. Role of MIF is well documented in leishmaniasis diseases, including Indian visceral leishmaniasis, where elevated level of serum MIF has been associated with VL phenotypes. However, there was no genetic study to correlate MIF variants in VL, therefore, we aimed to study the possible association of three reported MIF gene variants −794 CATT, −173G > C and non-coding RNA gene LOC284889 in Indian VL phenotype. Methods: Study subjects comprised of 214 VL patients along with ethnically and demographically matched 220 controls from VL endemic regions of Bihar state in India. Results: We found no significant difference between cases and controls in allelic, genotypic and haplotype frequency of the markers analysed [-794 CATT repeats (χ2 = 0.86; p = 0.35; OR = 0.85; 95% CI = 0.61–1.19); −173 G > C polymorphism (χ2 = 1.11; p = 0.29; OR = 0.83; 95% CI = 0.59–1.16); and LOC284889 (χ2 = 0.78; p = 0.37; OR = 0.86; 95% CI = 0.61–1.20)]. Conclusion: Since we did not find any significant differences between case and control groups, we conclude that sequencing of complete MIF gene and extensive study on innate and adaptive immunity genes may help in identifying genetic variations that are associated with VL susceptibility/resistance among Indians.
KW - Genetic polymorphism
KW - Indian population
KW - Leishmania major, Leishmania donovani
KW - Macrophage Migration Inhibitory Factor (MIF)
KW - Visceral leishmaniasis (VL)
UR - http://www.scopus.com/inward/record.url?scp=85059323200&partnerID=8YFLogxK
U2 - 10.1016/j.jiph.2018.12.011
DO - 10.1016/j.jiph.2018.12.011
M3 - Article
C2 - 30611734
AN - SCOPUS:85059323200
SN - 1876-0341
VL - 12
SP - 380
EP - 387
JO - Journal of Infection and Public Health
JF - Journal of Infection and Public Health
IS - 3
ER -